Showing results (1801-1810 of 4,056) with videos related to

Sort By:
Pageof 406
Translational Cancer Research|March 14, 2024
Comprehensive analysis of the effects of the cuprotosis-associated gene SLC31A1 on patient prognosis and tumor microenvironment in human cancerGuiqian Zhang, Ning Wang, Shixun Ma, et al.
Translational Cancer Research|March 14, 2024
Comparable prognosis of early gastric cancer between intestinal type and diffuse type in patients of age 75 and older: a SEER-based cohort studyPing Yin, Rencheng Cai, Xiaohua Zhou, et al.
Translational Cancer Research|March 14, 2024
Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinomaYangyang Zhou, Shimeng Zheng, Qihang Guo, et al.
Translational Cancer Research|March 14, 2024
An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodesFei Ren, Chenxuan Yang, Jiaxiang Liu, et al.
Translational Cancer Research|March 14, 2024
The diagnostic, prognostic, drug sensitivity and ceRNA internet of PPP4R1 in liver hepatocellular carcinoma (LIHC)Xiaowei Li, Yinglian Pan, Siren Feng, et al.
Translational Cancer Research|March 14, 2024
Multiomics combined with single-cell analysis shows that mitophagy-related genes could accurately predict the prognosis of patients with clear cell renal cell carcinomaHang Yin, Yonggui Xiao, Hubo Li, et al.
Translational Cancer Research|March 14, 2024
A centrosome-related gene signature for predicting the overall survival of uveal melanomaXin Yu, Xiaoyu Guo, Wenge Li, et al.
Translational Cancer Research|March 14, 2024
The value of a panel of circulating microRNAs in screening prostate cancerChen Sun, Chong Lu, Xinji Li, et al.
Translational Cancer Research|March 14, 2024
A postoperative tumor-specific death prediction model for patients with endometrial cancer: a retrospective studyHailong Chen, Weiwei Yan, Dechang Xu, et al.
Translational Cancer Research|March 14, 2024
Toripalimab plus lenalidomide for central nervous system recurrence in refractory CD5+ diffuse large B-cell lymphoma with MYD88 and CD79B comutation: a case reportXi Chen, Zhihan Zhang, Junbao Zhang, et al.
Pageof 406